AF

:   8‐demethyl‐8‐amino‐[d]{.smallcaps}‐riboflavin

ITC

:   isothermal titration calorimetry

MAD

:   multiple‐wavelength anomalous dispersion

MAF

:   8‐demethyl‐*N*‐8‐methylamino‐[d]{.smallcaps}‐riboflavin

RoF

:   roseoflavin

RosA

:   8‐demethyl‐*N*,*N*‐8‐amino‐[d]{.smallcaps}‐riboflavin dimethyltransferase

SAH

:   *S*‐adenosylhomocysteine

SAM

:   *S*‐adenosylmethionine

Introduction {#febs13690-sec-0001}
============

The Gram‐positive soil bacteria *Streptomyces davawensis* and *Streptomyces cinnabarinus* produce roseoflavin (RoF), the only known natural riboflavin (vitamin B~2~) analogue with antibiotic activity. In contrast to most other antibiotics, RoF has multiple cellular targets and negatively affects flavoproteins as well as FMN riboswitches [1](#febs13690-bib-0001){ref-type="ref"}, [2](#febs13690-bib-0002){ref-type="ref"}, [3](#febs13690-bib-0003){ref-type="ref"}, [4](#febs13690-bib-0004){ref-type="ref"}, [5](#febs13690-bib-0005){ref-type="ref"}, [6](#febs13690-bib-0006){ref-type="ref"}, [7](#febs13690-bib-0007){ref-type="ref"}, [8](#febs13690-bib-0008){ref-type="ref"}. RoF may be considered a natural anti‐metabolite, and was postulated to be biosynthesized from riboflavin through 8‐demethyl‐8‐amino‐[d]{.smallcaps}‐riboflavin (AF) and 8‐demethyl‐8‐methylamino‐riboflavin (MAF) [9](#febs13690-bib-0009){ref-type="ref"}, [10](#febs13690-bib-0010){ref-type="ref"}. The occurrence of the intermediates AF and MAF was confirmed by the discovery of the first enzyme of RoF biosynthesis, the *S*‐adenosylmethionine (SAM)‐dependent dimethyltransferase *N*,*N*‐8‐demethyl‐8‐amino‐[d]{.smallcaps}‐riboflavin dimethyltransferase (RosA) [11](#febs13690-bib-0011){ref-type="ref"}. This enzyme synthesizes RoF from AF (via MAF) in two consecutive methylation reactions, as shown in Scheme [1](#febs13690-fig-0013){ref-type="fig"}. The corresponding gene (*rosA*) is present in a cluster comprising ten genes. The remaining genes of this cluster were found not to be involved in RoF synthesis, and it is presently unclear which genes/enzymes are responsible for synthesis of the key intermediate AF [12](#febs13690-bib-0012){ref-type="ref"}.

![The catalytic reaction of RosA.](FEBS-283-1531-g013){#febs13690-fig-0013}

The important role of RosA for completion of RoF biosynthesis prompted us to determine the three‐dimensional structure of this enzyme and to investigate the mechanism of the consecutive methylation reactions in more detail. We show that RosA has a topology similar to other SAM‐dependent methyltransferases, containing a mainly α‐helical 'orthogonal bundle domain' and a Rossmann‐like fold. Determination of the three‐dimensional structure also enabled us to locate the binding sites for the substrates AF and SAM. In addition, we performed steady‐state and rapid reaction studies, and determined the dissociation constants for the substrates of RosA as well as for the products. It was found that AF and SAM bind independently to RosA according to a random‐order mechanism. The products of the RosA reaction, RoF and SAH, exhibit higher affinity for the protein than the substrates AF and SAM do, leading to competitive product inhibition. RosA is a comparably slow enzyme, with a turnover rate (*k* ~cat~) of 0.06 min^−1^ for the overall dimethylation reaction. As RoF is a more potent antibiotic than AF and MAF, the slow synthesis of RoF and the tight binding of products may contribute to protection of the strains *S. davawensis* and *S*. *cinnabarinus* from the antibiotic that they produce.

Results {#febs13690-sec-0002}
=======

Crystal structure of RosA {#febs13690-sec-0003}
-------------------------

Initial attempts to solve the structure of RosA by molecular replacement were unsuccessful despite a thorough search for appropriate template structures using the online tools [phyre2]{.smallcaps} [13](#febs13690-bib-0013){ref-type="ref"}, [fugue]{.smallcaps} [14](#febs13690-bib-0014){ref-type="ref"} and [caspr]{.smallcaps} [15](#febs13690-bib-0015){ref-type="ref"}. Therefore, RosA labelled with selenomethionine (SeMet) (seven methionine residues in 353 amino acids) was produced, and the structure was solved by multiple‐wavelength anomalous dispersion (MAD) using a single tetragonal crystal (Table [1](#febs13690-tbl-0001){ref-type="table-wrap"}). The structure (one protomer in the asymmetric unit) was partially refined to a resolution of 3.5 Å, and this model was then used to solve the structure of a triclinic crystal form (space group *P*1) by molecular replacement. This crystal contained six molecules per asymmetric unit, and the structure was refined at a resolution of 2.2 Å, yielding final values of *R* = 20% and *R* ~free~ = 25% (Table [2](#febs13690-tbl-0002){ref-type="table-wrap"}).

###### 

Statistics for the SeMet MAD datasets. Values in parentheses are for the highest‐resolution shell

                                 Peak                       Inflection                 Remote
  ------------------------------ -------------------------- -------------------------- --------------------------
  X‐ray source                   SLS X06DA‐PXIII                                       
  Wavelength (Å)                 0.9791                     0.9796                     0.9714
  Temperature (K)                100                        100                        100
  Space group                    *I*4~1~22                  *I*4~1~22                  *I*4~1~22
  Cell dimensions                                                                      
  *a* = *b*,*c* (Å)              112.54, 132.27             112.46, 132.48             112.60, 132.27
  Resolution (Å)                 47.04--3.35 (3.53--3.35)   47.02--3.54 (3.60--3.54)   47.06--3.42 (3.73--3.42)
  Total number of reflections    166 043 (22 355)           141 532 (20 491)           156 742 (21 751)
  Unique number of reflections   6400 (905)                 5454 (771)                 6031 (848)
  Multiplicity                   25.9 (27.7)                26.0 (26.6)                26.0 (25.6)
  Anomalous multiplicity         14.2 (13.1)                14.2 (14.1)                14.2 (13.7)
  Completeness (%)               99.9 (99.7)                100.0 (100.0)              99.9 (99.6)
  Anomalous completeness (%)     99.9 (99.4)                99.9 (99.4)                99.9 (99.3)
  *R* ~p.i.m.~ (%)               1.3 (5.9)                  1.0 (5.7)                  1.1 (6.3)
  *R* ~meas~ (%)                 6.4 (29.5)                 5.2 (29.8)                 5.6 (32.2)
  \<I/αI)\>                      48.3 (12.8)                51.1 (14.8)                50.0 (12.2)
  CC~1/2~                        1.000 (0.989)              1.000 (0.987)              1.000 (0.989)
  CC\*                           1.000 (0.995)              1.000 (0.995)              1.000 (0.997)

John Wiley & Sons, Ltd

###### 

Data collection and refinement statistics. Values in parentheses are for the highest‐resolution shell

                                 RosA (native)
  ------------------------------ ---------------------------------------------------------------------------
  Data collection                
  X‐ray source                   ESRF ID23‐1
  Wavelength (Å)                 1.000
  Temperature (K)                100 K
  Space group                    *P*1
  Cell dimensions                
  *a*,*b*,*c* (Å)                82.72, 82.76, 96.45
  α, β, γ (°)                    95.1, 98.7, 114.5
  Resolution (Å)                 34.77--2.22 (2.26--2.22)
  Total number of reflections    168 833 (3484)
  Unique number of reflections   86 780 (1838)
  Multiplicity                   1.9 (1.9)
  Completeness (%)               77.4 (33.0)
  *R* ~p.i.m.~ (%)               3.1 (39.8)
  *R* ~meas~ (%)                 4.3 (56.2)
  \<I/σ(I)\>                     12.7 (1.70)
  CC~1/2~                        0.999 (0.756)
  CC\*                           1.000 (0.928)
  Refinement                     
  *R* ~work~                     0.1949
  *R* ~free~                     0.2485
  Number of atoms                15 787
  Protein                        15 518
  Water                          269
  B‐factors (Å^2^)               
  Protein                        66.1
  Water                          48.9
  All atoms                      65.8
  RMSDs                          
  Bond lengths (Å)               0.003
  Bond angles (°)                0.620
  Ramachandran outliers (%)      0.15
  PDB ID                         [4D7K](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4D7K)

John Wiley & Sons, Ltd

The RosA protomer comprises two domains: a mainly α‐helical 'orthogonal bundle domain' and a Rossmann‐like domain (α/β twisted open sheet). The orthogonal bundle (five α‐helices and one antiparallel β‐sheet) consists of residues 1--98. Residues 99--178 form an inter‐domain region (five helices) that connects the Rossmann motif to the orthogonal bundle. The Rossmann motif (residues 179--353) comprises a seven‐stranded β‐sheet core consisting of five parallel and two antiparallel β‐strands, which are connected by two pairs of α‐helices (Fig. [1](#febs13690-fig-0001){ref-type="fig"}A). To classify the domains, we performed a [cath]{.smallcaps} database (<http://www.cathdb.info/>) search using the CATHEDRAL algorithm [16](#febs13690-bib-0016){ref-type="ref"}. The orthogonal bundle belongs to the CATH superfamily 'winged helix repressor DNA binding domain' (CATH classification: 1.10.10.10; Sequential Structure Alignment Program (SSAP) score = 87.6; RMSD = 2.7 Å) and the functional family 'caffeic acid 3‐*O*‐methyltransferase 1'. The Rossmann‐like domain was found to be a member of the CATH superfamily 'Vaccinia Virus protein VP39' (CATH classification: 3.40.50.150; SSAP score = 85.4, RMSD = 4.1 Å). The algorithm treated the inter‐domain residues as part of the Rossmann motif.

![Schematic representation of the structure of RosA. (A) Cartoon representation of the RosA protomer, showing α‐helices in red, β‐sheets in yellow, and loops in grey. (B) Cartoon representation of the RosA dimer with one protomer shown in red, yellow and grey, and the other in pale blue, green and grey.](FEBS-283-1531-g001){#febs13690-fig-0001}

A PISA analysis [17](#febs13690-bib-0017){ref-type="ref"} predicted that a dimer is the most probable oligomer of RosA in solution. This prediction was confirmed by size exclusion chromatography (Fig. [2](#febs13690-fig-0002){ref-type="fig"}). Dimerization occurs in a head‐to‐head arrangement (Fig. [1](#febs13690-fig-0001){ref-type="fig"}B), and is mediated by interactions of adjacent α‐helices of the bundle motif (residues 1--36 and residues 60--73), the inter‐domain α‐helices comprising residues 101--109 and residues 111--126, and one helix from the Rossmann motif (residues 293--305).

![Determination of the purity and native molecular mass of RosA using SDS/PAGE and FPLC. (A) Determination of the subunit molecular mass of RosA after purification by Ni‐Sepharose FPLC was performed by SDS/PAGE (12.5%). Lane 1, low‐molecular‐mass protein marker; lane 2, crude extract; lane 3, protein fraction after purification by Ni‐Sepharose FPLC. The subunit molecular mass of RosA was estimated to be 38 kDa. (B) Determination of the native molecular mass of RosA using Superdex 200 10/300 GL chromatography. (C) Plot of the partition coefficient (*K* ~av~) against the logarithm of molecular mass of standard proteins (ferritin, 440 kDa; aldolase, 158 kDa; conalbumin, 75 kDa; ovalbumin, 43 kDa; ribonuclease A, 13.7 kDa). The native molecular mass of RosA (filled circle) was estimated to be 77 kDa.](FEBS-283-1531-g002){#febs13690-fig-0002}

The RosA protomers in the asymmetric unit exhibit very similar structures. Pairwise superpositions of the Rossmann domains in the six crystallographically independent protomers yielded RMSD values in the range from 0.2 to 0.9 Å (for approximately 160 aligned Cα atoms). The same analysis yielded mean RMSD values of 0.3 and 0.6 Å for the N‐terminal and intermediate regions. The values are slightly higher for superpositions of the entire chains (1.2 Å) and the three dimers (1.6 Å).

To identify protein structures resembling RosA in terms of its tertiary structure, we performed a Dali server analysis [18](#febs13690-bib-0018){ref-type="ref"}. The structures with the highest *Z* scores were mitomycin 7‐*O*‐methyltransferase from *Streptomyces lavendulae* (PDB ID [3GWZ](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GWZ)), a probable phenazine‐specific methyltransferase from *Pseudomonas aeruginosa* (PDB ID [2IP2](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2IP2)), the CALO1 methyltransferase from *Micromonospora echinospora* (PDB ID [3LST](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LST)), and a caffeic acid *O*‐methyltransferase from *Sorghum bicolor* (PDB ID [4PGH](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PGH)), with *Z* scores of 33, 32, 30 and 30, respectively. These proteins share 21--35% sequence identity with RosA. Superposition with the most similar structure (3GWZ, 35% sequence identity, 76% query coverage) resulted in an RMSD of 3.5 Å for the isolated subunit (317 of 324 aligned Cα atoms) and 6.6 Å for the dimers (618 of 650 aligned Cα atoms). Superposition of the Rossmann domains of RosA (residues 179--345) and 3GWZ (residues 179--349) resulted in an RMSD of 0.9 Å (118 of 160 aligned Cα atoms). This indicates that, despite an overall low sequence identity, the structure of RosA, especially the Rossmann domain, closely resembles that of other methyltransferases.

Prediction of the SAM/SAH binding site {#febs13690-sec-0004}
--------------------------------------

Unfortunately, all efforts to co‐crystallize RosA with SAM, SAH, AF or combinations of these compounds and cofactors were unsuccessful. Therefore, we used structural bioinformatics methods to locate putative binding sites for the substrate and cofactor. A cavity analysis using the program [casox]{.smallcaps} [19](#febs13690-bib-0019){ref-type="ref"} yielded several cavities, but only one of those was large enough to accommodate AF and SAM, and was located at the interface between the Rossmann domain and the N‐terminal domain (Fig. [3](#febs13690-fig-0003){ref-type="fig"}A).

![Schematic representation of the predicted binding pocket of RosA. (A) Surface and cartoon representation of the binding pocket of RosA predicted using [casox]{.smallcaps} [19](#febs13690-bib-0019){ref-type="ref"}. (B) Cartoon representation of RosA with predicted binding of AF (shown as yellow sticks) and SAM (shown as orange sticks). Potential hydrogen bonding interactions are indicated by blue dashed lines. Water molecules are represented as red spheres. The distance between the reactive methyl group of SAM and the amino group of AF is indicated by a green dashed line.](FEBS-283-1531-g003){#febs13690-fig-0003}

In addition, the web tools [prosite]{.smallcaps} [20](#febs13690-bib-0020){ref-type="ref"}, [3dligandsite]{.smallcaps} [21](#febs13690-bib-0021){ref-type="ref"} and [coach]{.smallcaps} [22](#febs13690-bib-0022){ref-type="ref"} were used to predict and identify ligand binding regions in RosA. PROSITE identified a SAM binding region (residue 235--237) in the C‐terminal Rossmann domain. This finding is in line with results obtained using [3dligandsite]{.smallcaps},[coach]{.smallcaps} and CaSoX. [3dligandsite]{.smallcaps} identified 25 crystal structures of proteins structurally related to RosA with bound SAM or SAH, and predicted 22 residues that are putatively involved in cofactor binding to RosA. On the other hand, the program [coach]{.smallcaps} (<http://zhanglab.ccmb.med.umich.edu/COACH/>) found several structures of methyltransferases in complex with various ligands, and clustered them according to a confidence score (C‐score between 0 and 1). The best‐scored cluster predicted 13 consensus SAH/SAM binding residues with a C‐score of 0.54 and a cluster size (total number of templates in a cluster) of 103. Moreover, [coach]{.smallcaps} generated a structure of RosA with SAM bound in the predicted active site. All other ligand--enzyme complexes had significantly lower C‐scores. Among those structures with C‐scores between 0.5 and 0.05 were those with ligands such as *N*‐acetyl serotonin (C‐score 0.10), pisatin (C‐score 0.08) and 5‐(3,3‐dihydroxypropeny)‐3‐methoxy‐benzene‐1,2‐diol (C‐score 0.05). Flavin derivatives such as AF did not occur in these clusters identified by [coach]{.smallcaps}. However, a cluster with an even lower C‐score of 0.02 contained structures of methyltransferases with bound SAH and 4‐methoxy‐E‐rhodomycin. 4‐methoxy‐E‐rhodomycin resembles AF with regard to the planar ring system. A comparison of the modelled RosA--SAM complex with the structure of carminomycin 4‐*O*‐methyltransferase from *Streptomyces peucetius* (PDB ID [1TW2](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1TW2)), a representative of the 4‐methoxy‐E‐rhodomycin cluster, showed that, despite the low sequence identity of 33%, the Rossmann domain and especially the β‐sheet core appeared to be structurally conserved. Therefore, we superimposed the β‐sheet core residues of RosA and 1TW2 (RMSD 0.805 Å; 42 of 42 aligned Cα atoms), and aligned a molecule of AF with 4‐methoxy‐E‐rhodomycin bound to 1TW2 (Fig. [4](#febs13690-fig-0004){ref-type="fig"}A). The RosA--AF--SAM complex thus generated was energy‐minimized and analysed in terms of the binding interactions of AF and SAM (Figs [3](#febs13690-fig-0003){ref-type="fig"}B and [4](#febs13690-fig-0004){ref-type="fig"}B).

![Structure of the putative active site of RosA. (A) Close‐up view of the superimposed structures of RosA (shown in yellow) and carminomycin‐4‐*O*‐methyltransferase (PDB ID [1TW2](http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1TW2); shown in blue). Ligands of 1TW2 (*S*‐adenosylhomocysteine and 4‐methoxy‐E‐rhodomycin) are shown as blue sticks. AF and SAM are shown in their predicted binding modes as yellow and orange sticks, respectively. (B) Close‐up view of the predicted binding pocket of RosA. Potential hydrogen bonding with AF (shown in yellow) and SAM (shown in orange) is indicated by blue dashed lines. Water molecules are represented as red spheres. The distance between the reactive methyl group of SAM and the amino group of AF is indicated by a green dashed line.](FEBS-283-1531-g004){#febs13690-fig-0004}

Determination of dissociation constants {#febs13690-sec-0005}
---------------------------------------

Inspection of the AF and SAM binding sites in the RosA structure suggested that both substrates, AF and SAM, bind independently to their respective pockets. Thus we determined the dissociation constant for AF and SAM by isothermal titration calorimetry (ITC). As shown in Fig. [5](#febs13690-fig-0005){ref-type="fig"}A,C, titration with either AF or SAM produced exothermic signals that were fitted to a one‐binding‐site model, yielding dissociation constants of 10 ± 1 and 22 ± 2 μ[m]{.smallcaps}, respectively. Surprisingly, both products, i.e. RoF and SAH, bind approximately ten times more tightly than the substrates, displaying dissociation constants of 0.8 ± 0.05 and 2 ± 0.1 μ[m]{.smallcaps}, respectively (Fig. [5](#febs13690-fig-0005){ref-type="fig"}B,D).

![Binding of AF, RoF, SAM and SAH to RosA. Calorimetric titrations of RosA with AF (A), RoF (B), SAM (C) and SAH (D) were performed in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl at 25 °C using a VP‐ITC system (MicroCal). The dissociation constants for binding of AF, RoF, SAM and SAH to RosA were 10 ± 1, 0.8 ± 0.05, 22 ± 2 and 2 ± 0.1 μ[m]{.smallcaps}, respectively (three independent measurements for each ligand). Data were analysed by non‐linear least‐squares fitting using [origin]{.smallcaps} version 7.0 (MicroCal).](FEBS-283-1531-g005){#febs13690-fig-0005}

Ternary complex formation with substrates and products {#febs13690-sec-0006}
------------------------------------------------------

The catalytic methylation of AF by RosA was investigated by spectrophotometry using a stopped‐flow device and a conventional spectrophotometer, exploiting the spectral changes that occur during methylation \[λ~max~ (AF) = 478 nm; λ~max~ (RoF) = 505 nm\]. At low concentrations of RosA, the final absorption spectrum features an absorption maximum at 505 nm, which is characteristic of complete formation of RoF (Fig. [6](#febs13690-fig-0006){ref-type="fig"}A). However, at high concentrations of RosA the maximum at 505 nm is less pronounced (hypsochromic effect), and additional maxima at a shorter wavelength are observed (Fig. [6](#febs13690-fig-0006){ref-type="fig"}B,C). Analysis by HPLC revealed that RoF is the main product in both cases, suggesting that the observed spectral changes are due to formation of a complex with RosA and either SAM or SAH. The observed spectral differences suggest considerable changes in the flavin binding site upon formation of a ternary complex, and the UV/Vis absorption spectra of RoF in various solvents suggest that an apolar environment induces similar spectral changes to those observed in our experiments (Fig. [6](#febs13690-fig-0006){ref-type="fig"}D). In addition, it is conceivable that steric restriction induced in the ternary complex prevents de‐localization of the electron lone pair into the aromatic system of the isoalloxazine ring, resulting in the observed hypso‐ and hypochromic effect. Therefore, we assume that formation of the ternary complex generates a more apolar and sterically constrained environment in the RoF binding pocket. In order to reveal the nature of the ternary complex, we also determined the affinity of RosA for SAM and SAH in the presence of RoF. As shown in Fig. [7](#febs13690-fig-0007){ref-type="fig"}, the presence of RoF greatly decreases the affinity for SAM, yielding a dissociation constant of 180 ± 20 μ[m]{.smallcaps}, whereas the affinity of SAH is approximately fourfold higher (*K* ~d~ = 0.4 ± 0.05 μ[m]{.smallcaps}). Thus the ternary complex with SAH (product complex) is clearly favoured over a complex with SAM (mixed substrate/product complex).

![UV/Vis absorption spectra at various RosA concentrations. (A, B) Spectral changes during the reaction of 5 μ[m]{.smallcaps} AF and 0.8 m[m]{.smallcaps} SAM with 5 and 25 μ[m]{.smallcaps} RosA, respectively. The reactions were performed in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl, in a single‐mixing stopped‐flow spectrophotometer. (C) A solution of 20 μ[m]{.smallcaps} AF and 100 μ[m]{.smallcaps} RosA was pre‐incubated prior to addition of 2 m[m]{.smallcaps} SAM. All three reactions were run at 25 °C, and absorption spectra were recorded from 350 to 600 nm using a diode array. (D) Spectra for 25 μ[m]{.smallcaps} RoF in various solvents \[water, dimethylsulfoxide (DMSO) and ethyl acetate\] and for 15 μ[m]{.smallcaps} RoF in diethyl ether.](FEBS-283-1531-g006){#febs13690-fig-0006}

![Formation of a ternary complex comprising the RosA:RoF complex with SAH or SAM. (A) A solution of RosA (25 μ[m]{.smallcaps}) and RoF (5 μ[m]{.smallcaps}) was titrated with SAH (0--3 μ[m]{.smallcaps}). The absorption spectra were recorded from 300 to 700 nm using a UV/Vis spectrophotometer. The inset shows a plot of the absorption change at 485 nm as a function of SAH concentration. A hyperbolic fit to the experimental data yielded a dissociation constant of 0.4 ± 0.05 μ[m]{.smallcaps}. (B) A solution of RosA (25 μ[m]{.smallcaps}) and RoF (5 μ[m]{.smallcaps}) was titrated in tandem cuvettes with SAM (0--990 μ[m]{.smallcaps}). The inset shows a plot of the absorption change at 485 nm as a function of SAM concentration. A hyperbolic fit to the experimental data yielded a dissociation constant of 180 ± 20 μ[m]{.smallcaps}. Both titrations were performed in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl.](FEBS-283-1531-g007){#febs13690-fig-0007}

Next, we performed difference absorption spectroscopy to determine the dissociation constants of RoF from the binary complex of RosA:SAH and RosA:SAM, respectively, as well as the affinity of AF for the RosA:SAH complex. The former experiments, shown in Fig. [8](#febs13690-fig-0008){ref-type="fig"}A,B, yielded virtually identical dissociation constants of 14 ± 2 and 15 ± 2 μ[m]{.smallcaps}, demonstrating that SAH and SAM cause similar decreases in the binding affinity of RoF by a factor of 17--18. In contrast to product binding, AF binding to RosA is not affected by SAH, as the determined dissociation constant of 10 ± 1 μ[m]{.smallcaps} is almost identical to that observed in the absence of SAH (Fig. [9](#febs13690-fig-0009){ref-type="fig"}). Table [3](#febs13690-tbl-0003){ref-type="table-wrap"} lists the dissociation constants obtained by ITC or spectrophotometric titrations.

![Formation of a ternary complex comprising the RosA:SAH or RosA:SAM complex with RoF. (A) A solution of RosA (25 μ[m]{.smallcaps}) and SAH (150 μ[m]{.smallcaps}) was titrated with RoF (0--18.2 μ[m]{.smallcaps}). The absorption changes from the UV/Vis difference titrations were recorded from 300 to 700 nm using a UV/Vis spectrophotometer. The inset shows a plot of the absorption change at 510 nm as a function of RoF concentration. A hyperbolic fit to the experimental data yielded a dissociation constant of 14 ± 2 μ[m]{.smallcaps}. (B) A solution of RosA (30 μ[m]{.smallcaps}) and SAM (2 m[m]{.smallcaps}) was titrated in tandem cuvettes with RoF (0--29.2 μ[m]{.smallcaps}). The inset shows a plot of the absorption change at 510 nm as a function of the RoF concentration. A hyperbolic fit to the experimental data yielded a dissociation constant of 15 ± 2 μ[m]{.smallcaps}. Both titrations were performed in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl.](FEBS-283-1531-g008){#febs13690-fig-0008}

![AF binds independently to RosA in the presence of SAH. A solution of RosA (25 μ[m]{.smallcaps}) and SAH (150 μ[m]{.smallcaps}) was titrated with AF (0--34.0 μ[m]{.smallcaps}). The absorption spectra of the titrations were recorded from 300 to 700 nm using a UV/Vis spectrophotometer. The inset shows a plot of the absorption change at 495 nm as a function of SAH concentration. A hyperbolic fit to the experimental data yielded a dissociation constant of 10 ± 1 μ[m]{.smallcaps}.](FEBS-283-1531-g009){#febs13690-fig-0009}

###### 

Dissociation constants (*K* ~d~, μ[m]{.smallcaps}) of RosA for AF, RoF, SAH and SAM, determined by ITC and UV/Vis absorption titrations. Values marked with asterisk were obtained from ITC measurements. Values marked with hash symbols (\#) were obtained from UV/Vis absorption titrations

  In the presence of   AF           RoF            SAM            SAH
  -------------------- ------------ -------------- -------------- ----------------
  --                   10 ± 1\*     0.8 ± 0.05\*   22 ± 2\*       2 ± 0.1\*
  RoF                                              180 ± 20^\#^   0.4 ± 0.05^\#^
  SAM                               15 ± 2^\#^                    
  SAH                  10 ± 1^\#^   14 ± 2^\#^                    

John Wiley & Sons, Ltd

Mechanistic studies of the dimethylation reaction catalysed by RosA {#febs13690-sec-0007}
-------------------------------------------------------------------

With regard to the reaction mechanism, the structure of RosA as well as the independent binding of AF and SAM suggest that the enzyme operates by a random‐order kinetic mechanism, as shown in Scheme [2](#febs13690-fig-0014){ref-type="fig"}. To test this hypothesis, we performed a series of pre‐steady‐state kinetic measurements in the stopped‐flow device. In these experiments, different mixing orders were employed, and the progress of the reaction was monitored at 479 and 530 nm. As shown in Fig. [10](#febs13690-fig-0010){ref-type="fig"}A, the rate of reaction was independent of the experimental set‐up, i.e. whether RosA was directly mixed with AF and SAM or pre‐incubated with either of the substrates. To obtain further insight into the kinetic mechanism, we performed a set of steady‐state experiments at various AF and RoF concentrations. As shown in Fig. [10](#febs13690-fig-0010){ref-type="fig"}B, a primary reciprocal plot of the reaction velocity against the reciprocal SAM concentration resulted in a set of converging lines in accordance with a random‐order mechanism. From a re‐plot of the primary data, i.e. slopes and *y*‐axis intercepts versus the reciprocal AF concentration (Fig. [10](#febs13690-fig-0010){ref-type="fig"}B, insets), the Michaelis constants of AF and SAM were deduced to be 4 and 70 μ[m]{.smallcaps}, and the *k* ~cat~ was estimated as 0.06 min^−1^ (Table [4](#febs13690-tbl-0004){ref-type="table-wrap"}).

![Scheme of the methylation reactions catalysed by RosA following a random‐order 'bi‐bi' mechanism.](FEBS-283-1531-g014){#febs13690-fig-0014}

![Steady‐state kinetics of RosA and substrate binding sequence of the RosA reaction. (A). The RosA reaction was performed at 25 °C in a stopped‐flow spectrophotometer using different mixing orders for the substrates AF and SAM. The traces shown represent AF consumption and RoF formation, respectively, at 479 nm (solid lines) and 530 nm (dotted lines). The red trace represents the reaction of RosA:AF (5 μ[m]{.smallcaps} RosA and 5 μ[m]{.smallcaps} AF) with 80 μ[m]{.smallcaps} SAM. The blue trace represents the reaction of RosA:SAM (5 μ[m]{.smallcaps} RosA and 80 μ[m]{.smallcaps} SAM) with 5 μ[m]{.smallcaps} AF. The green trace represents the reaction of RosA (5 μ[m]{.smallcaps}) with AF (5 μ[m]{.smallcaps}) and SAM (80 μ[m]{.smallcaps}). All solutions were prepared in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl. (B) Double‐reciprocal plot of the two‐substrate kinetics of the RosA reaction. The enzyme catalytic assay was performed at 25 °C in a spectrophotometer, measuring the increase in RoF formation at 530 nm. The reaction contained 5 μ[m]{.smallcaps} RosA in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl plus various concentrations of AF (20--100 μ[m]{.smallcaps}) and SAM (20--250 μ[m]{.smallcaps}) as indicated. Insets 1 and 2 represent secondary plots of the slope and *y*‐axis intercept obtained from the primary plot against reciprocal AF concentration, resulting in a $K_{m}^{AF}$ of 4 μ[m]{.smallcaps}, a $K_{m}^{SAM}$ of 70 μ[m]{.smallcaps}, and a *k* ~cat~ of 0.06 min^−1^.](FEBS-283-1531-g010){#febs13690-fig-0010}

###### 

Kinetic parameters for the RosA reaction

  Parameter                          Value
  ---------------------------------- -------
  $K_{m}^{AF}$ (μ[m]{.smallcaps})    4
  $K_{m}^{SAM}$ (μ[m]{.smallcaps})   70
  *k* ~cat~ (min^−1^)                0.06

John Wiley & Sons, Ltd

As generation of RoF from AF requires two consecutive methylation steps, we also wished to obtain insight into the individual methylation reactions. Towards this aim, we analysed the reaction under single‐turnover conditions at two different wavelengths that represent the consumption of the substrate (λ = 479 nm) and the generation of the product (λ = 530 nm). The reaction of RosA (20 μ[m]{.smallcaps}) in the presence of AF (20 μ[m]{.smallcaps}) was investigated by mixing with various concentrations of SAM (80--2000 μ[m]{.smallcaps}). The rates of the observed spectral changes at 479 and 530 nm were biphasic, and therefore fitted to two rate equations (Fig. [11](#febs13690-fig-0011){ref-type="fig"}A). The first phase consisted of a decrease in absorption at 479 nm and a concurrent small increase at 530 nm (approximately 25%). This first phase was interpreted to represent monomethylation of AF to MAF, and showed a hyperbolic dependence on the SAM concentration, yielding a limiting rate of 0.5 ± 0.05 min^−1^ and an equilibrium constant of 180 ± 40 μ[m]{.smallcaps} (Fig. [11](#febs13690-fig-0011){ref-type="fig"}B). The second slower phase corresponded to a decrease at 479 nm and a concomitant increase at 530 nm. This phase showed an inverse dependence on the SAM concentration approaching 0.05 ± 0.002 min^−1^ (Fig. [11](#febs13690-fig-0011){ref-type="fig"}C). The latter result suggested that monomethylation of AF generates an inhibitory product that prevents binding of SAM. In fact, our binding studies have revealed that SAH binds much more strongly to RosA than SAM does (Table [3](#febs13690-tbl-0003){ref-type="table-wrap"}). Furthermore, the presence of RoF further weakens SAM binding but the affinity for SAH is increased (Table [3](#febs13690-tbl-0003){ref-type="table-wrap"}). Thus we reasoned that SAH, which is produced in the first monomethylation reaction, acts as a competitive inhibitor of SAM. To test this hypothesis, we determined the rate of the methylation reaction as a function of SAM and SAH concentrations. The initial velocities were determined as a function of SAM concentration at various fixed concentrations of SAH to obtain information on the type of inhibition. However, this plot did not allow us to discern the inhibition type, i.e. competitive, non‐competitive or uncompetitive. As it was shown that SAH binds more tightly to RosA than SAM does, we used the linearized Henderson equation for data analysis [23](#febs13690-bib-0023){ref-type="ref"}. The resulting Henderson plot, as shown in Fig. [12](#febs13690-fig-0012){ref-type="fig"}A, yielded a set of lines that converge on the *y* axis. A re‐plot of the slopes, as shown in the inset to Fig. [12](#febs13690-fig-0012){ref-type="fig"}A, allows determination of the inhibition constant of SAH as 7 μ[m]{.smallcaps}. This value is in the same range as the dissociation constant of SAH in the presence of RoF, suggesting that MAF and RoF have similar effects on SAH binding (Table [3](#febs13690-tbl-0003){ref-type="table-wrap"}). Thus we conclude that the observed rate decline of the second kinetic phase is due to the competitive effect of SAH, with the limiting value corresponding to *k* ~off~ of SAH.

![Kinetic reaction of RosA:AF (1 : 1 ratio) with SAM. (A) Reaction of RosA:AF with SAM. A solution of RosA (20 μ[m]{.smallcaps}) and AF (20 μ[m]{.smallcaps}) in 50 m[m]{.smallcaps} Tris/HCl, pH 8.0, containing 100 m[m]{.smallcaps} NaCl, was mixed with various concentrations of SAM (80--2000 μ[m]{.smallcaps}), and the reaction was monitored by the absorption change at 25 °C on a spectrophotometer. All concentrations are shown as final concentrations. The absorption decrease at 479 nm (left *y*‐axis) and increase at 530 nm (right *y*‐axis) are shown. (B) *k* ~obs~ values for the first phase of the reaction representing monomethylation step were plotted as a function of concentration of SAM, resulting a rate constant of 0.5 ± 0.05 min^−1^ with a *K* ~d~ of 180 ± 40 μ[m]{.smallcaps}. (C) Plot of *k* ~obs~ for the second phase against the concentration of SAM. The plot was fitted by non‐linear curve fitting, consistent with a rate constant of 0.05 ± 0.002 min^−1^.](FEBS-283-1531-g011){#febs13690-fig-0011}

![Product inhibition of the RosA reaction. (A) SAH inhibition of the RosA reaction. A Henderson plot for tight‐binding inhibition by SAH with respect to SAM was obtained by plotting \[I\]/(1 -- *v* ~i~/*v* ~0~) as a function of *v* ~0~/*v* ~i~ at various fixed concentrations of SAM as indicated. Initial rates of RosA reactions were measured by the absorption change at 530 nm over time. The reactions contained 5 μ[m]{.smallcaps} RosA, 200 μ[m]{.smallcaps} AF, various fixed SAM concentrations (20--100 μ[m]{.smallcaps}), and various concentrations of SAH (0, 10, 20, 40 and 80 μ[m]{.smallcaps}). The inset is a secondary plot of $K_{i}^{app}$, slopes obtained from the primary plot, against the concentration of SAM yielding a $K_{i}^{app}$ of 7 μ[m]{.smallcaps}. (B) RoF inhibition of the RosA reaction. A Henderson plot for tight‐binding inhibitor of product inhibition by RoF with respect to AF was obtained by plotting \[I\]/(1 -- *v* ~i~/*v* ~0~) as a function of *v* ~0~/*v* ~i~ at various fixed concentrations of AF as indicated. Initial rates of RosA reactions were measured by the absorption change at 530 nm by time. The reactions consisted of 5 μ[m]{.smallcaps} RosA, 250 μ[m]{.smallcaps} SAM, various fixed AF concentrations (20--100 μ[m]{.smallcaps}), and various concentrations of RoF (0, 10, 15, 25 and 40 μ[m]{.smallcaps}). The inset is a secondary plot of $K_{i}^{app}$, slopes obtained from the primary plot, against concentration of AF, yielding a $K_{i}^{ROF}$ of 27 μ[m]{.smallcaps}.](FEBS-283-1531-g012){#febs13690-fig-0012}

In a similar set of experiments, it was shown that RoF is a competitive inhibitor of AF, exhibiting a *K* ~i~ value of 27 μ[m]{.smallcaps} (Fig. [12](#febs13690-fig-0012){ref-type="fig"}B), which represents the dissociation constant of RoF in the presence of SAM (compare Tables [3](#febs13690-tbl-0003){ref-type="table-wrap"} and [5](#febs13690-tbl-0005){ref-type="table-wrap"}).

###### 

Product inhibition pattern and dissociation constants (*K* ~i~) of the RosA--product inhibitor complex. Product inhibition was fitted to the tight‐binding inhibitor model

  Product   Type of inhibition   *K* ~i~ (μ[m]{.smallcaps})
  --------- -------------------- ----------------------------
  RoF       Competitive (AF)     27
  SAH       Competitive (SAM)    7

John Wiley & Sons, Ltd

Discussion {#febs13690-sec-0008}
==========

Structure analysis revealed that RosA adopts a topology that is characteristic of SAM‐dependent methyltransferases. Although attempts to obtain structural information for complexes with AF, SAM and SAH were unsuccessful, further inspection of the active site and the AF and SAM binding pockets provided useful hints for mechanistic considerations that were tested by binding studies and steady‐state as well as pre‐steady‐state kinetic experiments. The final biosynthesis of RoF from AF by RosA is unusual in the sense that the enzyme performs two consecutive methylations in the same active site, and hence SAH must dissociate to make room for another SAM while the monomethylated intermediate, MAF, may remain bound to the flavin‐binding pocket. This complexity of the overall conversion of AF to RoF was analysed by binding studies as well as kinetic experiments to evaluate the interaction of substrates and products in the RosA‐catalysed reaction. Much to our surprise, our binding studies revealed that both products, RoF and SAH, bind approximately ten times more tightly to RosA than AF and SAM do (Table [3](#febs13690-tbl-0003){ref-type="table-wrap"}). Interestingly, the affinity of RoF decreased approximately 20‐fold in the presence of SAM and SAH, whereas the affinities of SAM and SAH respond differently to the presence of RoF, i.e. the dissociation constant for SAM increased approximately eightfold and that for SAH decreased fourfold. These relative binding affinities clearly suggest that the ternary complex observed in spectrophotometric experiments (Fig. [6](#febs13690-fig-0006){ref-type="fig"}) consisted of RoF and SAH bound to RosA. The fact that the tightest binary complex formed is that between RosA and RoF also suggested a potential mechanism to control the concentration of free RoF in *S. davawensis*. It may be assumed that the concentrations of both SAM and SAH are too low to form a ternary complex with RosA:RoF, and thus RoF inhibits binding of AF and further generation of the product. This scenario is also supported by the competitive inhibition of the RosA‐catalysed methylation of AF by RoF (Fig. [12](#febs13690-fig-0012){ref-type="fig"}). The resistance of *S. davawensis* to RoF appears to be related to the ability of the *ribB* FMN riboswitch to discriminate between FMN and roseoflavin‐5'‐phosphate [7](#febs13690-bib-0007){ref-type="ref"}. However, it is not clear yet whether other additional mechanisms contribute to resistance in *S. davawensis*. Therefore, it is plausible that the tight binding of RoF to RosA constitutes an additional mechanism to confer resistance towards RoF. Although it is still unknown how RoF is eventually secreted, it is conceivable that RosA also serves as a chaperone to guide RoF to the secretion machinery that is in charge of its translocation from the cell into the environment.

The X‐ray crystallographic structure of RosA suggested that both substrates, AF and SAM, bind independently to their respective pockets. This feature was confirmed by kinetic experiments that demonstrated a random‐order binding mechanism for the first methylation reaction yielding MAF and SAH (Fig. [10](#febs13690-fig-0010){ref-type="fig"} and Scheme [3](#febs13690-fig-0015){ref-type="fig"}). The rate of monomethylation of AF to MAF showed a hyperbolic dependence on the SAM concentration, yielding a limiting rate of 0.5 ± 0.05 min^−1^ (Fig. [11](#febs13690-fig-0011){ref-type="fig"}B). Surprisingly, the subsequent reaction phase was characterized by an inverse dependence on the SAM concentration, approaching a limiting rate of 0.05 ± 0.002 min^−1^ (Fig. [11](#febs13690-fig-0011){ref-type="fig"}C). As noted above, SAH binds tightly to RosA, and its affinity is enhanced in the presence of RoF (Table [3](#febs13690-tbl-0003){ref-type="table-wrap"}). It is likely that the binding affinity of SAH in the presence of MAF is in the same range, i.e. between 2 ± 0.1 and 0.4 ± 0.05 μ[m]{.smallcaps}, and thus the second methylation reaction depends on the rate of dissociation of SAH (*k* ~off~). This *k* ~off~ appears to be the limiting step for conversion of MAF to RoF, and therefore the intrinsic rate for this reaction step is not accessible in our kinetic experiments. A summary of the reaction steps characterized in this study is shown in Scheme [3](#febs13690-fig-0003){ref-type="fig"}.

![Suggested reaction scheme for the reactions catalysed by RosA based on our binding studies and kinetic measurements.](FEBS-283-1531-g015){#febs13690-fig-0015}

Experimental procedures {#febs13690-sec-0009}
=======================

Reagents {#febs13690-sec-0010}
--------

All chemicals and reagents were of the highest purity commercially available from Sigma‐Aldrich (St. Louis, MO, USA) and Merck (Darmstadt, Germany). AF was a generous gift from Sandro Ghisla (Universität Konstanz, Germany). Ni‐NTA‐agarose was obtained from GE Healthcare (Little Chalfont, UK). RosA was over‐produced in *Escherichia coli*, and purified as previously described [11](#febs13690-bib-0011){ref-type="ref"}. The concentrations of the following compounds were determined spectrophotometrically using these extinction coefficients: AF, ε~490~ = 42.0 m[m]{.smallcaps} ^−1^·cm^−1^; RoF, ε~505~ = 31.1 m[m]{.smallcaps} ^−1^·cm^−1^ [24](#febs13690-bib-0024){ref-type="ref"}; SAM and SAH, ε~260~ = 15.4 m[m]{.smallcaps} ^−1·^cm^−1^ [25](#febs13690-bib-0025){ref-type="ref"}; RosA (based on amino acid sequence) = 27.1 m[m]{.smallcaps} ^−1·^cm^−1^.

Expression and purification {#febs13690-sec-0011}
---------------------------

Heterologous production and purification of recombinant hexahistidine‐tagged RosA from *S. davawensis* was performed as described previously [11](#febs13690-bib-0011){ref-type="ref"}. *E. coli* Rosetta 2 (DE3) was transformed using pET24a(+)*rosA‐His* ~*6*~ (pFJ02) [11](#febs13690-bib-0011){ref-type="ref"}. One of the transformant strains was used to inoculate a pre‐culture that was aerobically incubated at 37 °C for 16 h (200 rpm) in lysogeny broth containing 50 μg·mL^−1^ kanamycin. The cells were harvested by centrifugation (5000 ***g*** at 4 °C for 30 min), and washed three times using PBS (10 min per wash at 4 °C). The cells were then suspended in 30 mL PBS and used as an inoculum for a 15‐L bioreactor (Bioengineering AG, Wald, Switzerland). Cell growth was allowed to proceed for 7 h at 750 rpm, 37 °C, with an aeration of 1 L of oxygen per L of culture per minute in a total volume of 10 L until the cells reached an absorption at 600 nm of 0.8. Synthesis of the recombinant protein was induced by addition of 0.5 m[m]{.smallcaps} isopropyl‐β‐[d]{.smallcaps}‐thiogalactopyranoside. The culture was further incubated for 16 h at 30 °C until an attenuance at 600 nm of 1.2 was reached. Cells were harvested by centrifugation at 5000 ***g*** (4 °C).

To produce selenomethionine‐containing hexahistidine‐tagged RosA, the expression protocol for native RosA was slightly altered. *E. coli* BL834 (DE3) was transformed with pFJ02, and incubated for 7 h at 37 °C and 200 rpm in selenomethionine minimal medium [26](#febs13690-bib-0026){ref-type="ref"} supplemented with 50 μg·mL^−1^ kanamycin. The pre‐culture was harvested by centrifugation at 5000 ***g*** (4 °C) and used as an inoculum for a 15‐L bioreactor (Bioengineering AG). Synthesis of the recombinant protein was induced at when the cells reached an attenuance at 600 nm of 0.8 by adding 0.5 m[m]{.smallcaps} isopropyl‐β‐[d]{.smallcaps}‐thiogalactopyranoside. Cells were harvested when they reached an attenuance at 600 nm of 1.2, by centrifugation at 5000 ***g*** (4 °C). All cell pellets were frozen immediately after harvesting and stored at −80 °C.

The enzyme was purified using an ÄKTApurifier^™^ system (GE Healthcare). Frozen cell pellets of *E. coli* Rosetta 2 (DE3) and BL834 (DE3) over‐producing hexahistidine‐tagged RosA and SeMet‐RosA, respectively, was resuspended in 50 mL HisTrap binding buffer. This buffer contained 20 m[m]{.smallcaps} Na~2~HPO~4~, pH 7.4, 500 m[m]{.smallcaps} NaCl and 20 m[m]{.smallcaps} imidazole, and was supplemented with protease inhibitors (Roche cOmplete^™^ EDTA‐free protease inhibitor cocktail, Roche, Basel, Switzerland). For purification of SeMet‐RosA, the HisTrap buffer also contained 2 m[m]{.smallcaps} β‐mercaptoethanol. The cells were disrupted using a French press (three cycles, 2 × 10^8^ Pa, 10 °C). The cell‐free extract was cleared by centrifugation at 10 000 ***g*** for 30 min at 4 °C. The supernatant was again centrifuged at 100 000 ***g*** for 30 min at 4 °C to remove cell debris and unbroken cells. The cleared lysate was filtered (0.45 μm), equilibrated with loading buffer (20 m[m]{.smallcaps} Na~2~HPO~4~, pH 7.4, 500 m[m]{.smallcaps} NaCl, 20 m[m]{.smallcaps} imidazole, plus 2 m[m]{.smallcaps} β‐mercaptoethanol for SeMET‐RosA) and applied to a 5 mL HisTrap column (HisTrap^™^ HP; GE Healthcare). Gradient elution of the hexahistidine‐tagged protein was performed using 0 to 50% elution buffer (20 m[m]{.smallcaps} Na~2~HPO~4~, pH 7.4, 500 m[m]{.smallcaps} NaCl, 500 m[m]{.smallcaps} imidazole, plus 2 m[m]{.smallcaps} β‐mercaptoethanol for SeMET‐RosA). Eluted enzyme fractions were pooled and desalted using a HiTrap^™^ desalting column (GE Healthcare), and equilibrated in a buffer containing 20 m[m]{.smallcaps} Tris/HCl, pH 8.0, with 2 m[m]{.smallcaps} β‐mercaptoethanol for SeMET‐RosA only. To achieve enzyme purity appropriate for crystallization experiments, an additional ion exchange chromatography step was performed. The enzyme fraction was applied to a MonoQ 5/50 GL column (GE Healthcare) and eluted using a linear gradient from 0 to 100% elution buffer comprising 20 m[m]{.smallcaps} Tris/HCl, pH 8.0, 500 m[m]{.smallcaps} NaCl (plus 2 m[m]{.smallcaps} β‐mercaptoethanol for SeMET‐RosA only). Aliquots of the fractions were analysed by SDS/PAGE with staining using Coomassie Brilliant Blue R‐250. The homogeneous fractions were tested directly for RosA activity (see below).

Determination of native and subunit molecular masses of RosA {#febs13690-sec-0012}
------------------------------------------------------------

To determine the subunit molecular mass of RosA purified protein was loaded onto SDS/PAGE (12.5%). Protein molecular mass markers used were Low Molecular Weight protein markers (GE Healthcare, Little Chalfont, UK) containing phosphorylase b (97 kDa), albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (20 kDa), and α‐lactalbumin (14.4 kDa). The gel was stained with Coomassie Brilliant Blue R‐250 prior to destaining (10% ethanol, 10% glacial acetic acid in water).

To determine the native molecular mass of RosA gel filtration chromatography at 25 °C was performed. The protein solution was loaded onto a Superdex 200 10/300 GL column attached to a AKTApurifier^™^ system (GE Healthcare) and then eluted with elution buffer (50 m[m]{.smallcaps} Tris‐HCl, pH 8.0 containing 100 m[m]{.smallcaps} NaCl) at a flow rate of 0.5 mL·min^−1^. Protein standard markers used in this experiment were ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa), and ribonuclease a (13.7 kDa).

Isothermal titration calorimetry (ITC) {#febs13690-sec-0013}
--------------------------------------

All of the experiments to determine dissociation constants (*K* ~d~) for AF, RoF, SAM and SAH to RosA were performed at 25 °C in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl using a VP‐ITC system (MicroCal, Northampton, MA, USA). All solutions were degassed before measurements. Titration experiments for AF and RoF binding to RosA (30 μ[m]{.smallcaps}, 1.42 mL) consisted of 20 injections (15 μL; duration, 30 s; spacing time, 250 s) of a solution containing 0.6 m[m]{.smallcaps} AF and 0.48 m[m]{.smallcaps} RoF. Determination of the *K* ~d~ for SAM and SAH was performed by titration (20 injections) of 0.35 m[m]{.smallcaps} SAM (15 μL; duration, 30 s; spacing time, 250 s) and 0.48 m[m]{.smallcaps} SAH (15 μL; duration, 30 s; spacing time, 250 s) to a RosA solution (30 μ[m]{.smallcaps}, 1.42 mL). The ITC raw data were analysed using [origin]{.smallcaps} version 7.0 (MicroCal).

Spectrophotometric titration of RosA with AF, RoF, SAM and SAH {#febs13690-sec-0014}
--------------------------------------------------------------

UV/Vis absorption spectra were recorded using a Specord 200 Plus spectrophotometer (Analytik Jena, Jena, Germany) at 25 °C. To determine the dissociation constants for binding of RoF and AF to the RosA:SAH complex by means of difference spectrophotometry, titrations were performed at 25 °C in tandem cuvettes. All solutions were prepared in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl. A solution (0.8 mL) containing RosA (25 μ[m]{.smallcaps}) and SAH (150 μ[m]{.smallcaps}) was placed in one of the two chambers of the sample and reference cell. The other chamber of each tandem cuvette was filled with the same volume of buffer only. After recording a baseline, RoF (0--18.2 μ[m]{.smallcaps}) or AF (0--34.0 μ[m]{.smallcaps}) were added to the solution containing RosA and SAH in the sample cell and to the buffer in the reference cell at 2 min intervals. Absorption spectra were recorded from 300 to 700 nm after each titration step. Similar titrations of the RosA:SAM complex (30 μ[m]{.smallcaps} RosA and 2 m[m]{.smallcaps} SAM) with RoF were performed by addition of RoF (0--29.2 μ[m]{.smallcaps}) to the complex in the sample cell and to the buffer in the reference cell. For determination of the dissociation constants for SAH and SAM from the binary RosA:RoF complex (25 μ[m]{.smallcaps} RosA and 5 μ[m]{.smallcaps} RoF), SAH and SAM were titrated to final concentrations of 3 and 990 μ[m]{.smallcaps}, respectively. Absorption changes were recorded from 300 to 700 nm, and were plotted against the concentration of ligands. The dissociation constants were obtained by fitting the data using Levenberg--Marquardt algorithm (Eqn [(1)](#febs13690-disp-0001){ref-type="disp-formula"}) implemented in the [kaleidagraph]{.smallcaps} software (Synergy Software, Reading, PA, USA): $$\Delta A = \frac{\Delta A_{\max}{\lbrack L\rbrack}}{K_{d} + {\lbrack L\rbrack}}$$

Steady‐state kinetics of RosA {#febs13690-sec-0015}
-----------------------------

RosA catalyses the *N*,*N*‐dimethylation of AF to yield RoF as the final product. Steady‐state kinetic measurements were performed at 25 °C using a spectrophotometer. The assay reaction contained 5 μ[m]{.smallcaps} RosA, various concentrations of AF (20--100 μ[m]{.smallcaps}), and various concentrations of SAM (20--250 μ[m]{.smallcaps}) in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl. Progress of the RosA reactions was monitored at 530 nm (ε~530~ = 25.2 m[m]{.smallcaps} ^−1^·cm^−1^), at which wavelength RoF formation may be monitored without interference from other chromophores. Initial rates were obtained using [kinetic studio]{.smallcaps} software (TgK Scientific Ltd, Bradford‐on‐Avon, UK). A double‐reciprocal plot of the initial rate and the substrate concentration provides the steady‐state kinetic parameters, and also provides information on the mechanism of a two‐substrate enzyme reaction according to Dalziel\'s equation (Eqn [(2)](#febs13690-disp-0002){ref-type="disp-formula"}), in which *e*/*v* is the ratio between the enzyme concentration and the initial velocity, \[A\] and \[B\] are the concentrations of substrates A and B, respectively, and Φ values are Dalziel\'s coefficients [27](#febs13690-bib-0027){ref-type="ref"}: $$\frac{e}{v} = \Phi_{0} + \frac{\Phi_{A}}{\lbrack A\rbrack} + \frac{\Phi_{B}}{\lbrack B\rbrack} + \frac{\Phi_{AB}}{\lbrack A\rbrack\lbrack B\rbrack}$$

Product inhibition of RosA {#febs13690-sec-0016}
--------------------------

Enzymatic activity of RosA in the presence of the reaction products RoF and SAH was studied by measuring the initial rate of the reaction at 25 °C using a spectrophotometer. The assay reaction contained 5 μ[m]{.smallcaps} RosA, various fixed concentrations of AF (20--100 μ[m]{.smallcaps}) and various fixed concentrations of SAM (20--100 μ[m]{.smallcaps}) in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl. Concentrations of RoF in the range of 0--40 μ[m]{.smallcaps} were used with various concentrations of AF and a fixed concentration of SAM (250 μ[m]{.smallcaps}). The inhibition by SAH was analysed at various concentrations of SAH and SAM using a fixed concentration of AF (200 μ[m]{.smallcaps}). Initial rates were obtained from linear data fitting using [kinetic studio]{.smallcaps} software (TgK Scientific Ltd). A Henderson plot of \[I\]/(1 -- *v* ~i~/*v* ~0~) and the reciprocal of the fractional initial velocity (*v* ~0~/*v* ~i~) (Eqns [(3)](#febs13690-disp-0003){ref-type="disp-formula"} and [(4)](#febs13690-disp-0004){ref-type="disp-formula"}) was used to obtain inhibition constants and information on the inhibition mechanism [23](#febs13690-bib-0023){ref-type="ref"}: $$\frac{\lbrack I\rbrack}{1 - \frac{v_{i}}{v_{0}}} = K_{i}^{app}(\frac{v_{0}}{v_{i}}) + {\lbrack E\rbrack}$$and for a competitive inhibitor:$$K_{i}^{app} = K_{i}(1 + \frac{\lbrack S\rbrack}{K_{m}})$$

In Eqns [(3)](#febs13690-disp-0003){ref-type="disp-formula"} and [(4)](#febs13690-disp-0004){ref-type="disp-formula"}, \[I\] is the concentration of inhibitor (i.e. RoF and SAH), *v* ~0~ and *v* ~i~ are the initial velocity of a reaction in the absence and presence of a inhibitor, respectively, \[E\] is the total enzyme concentration, \[S\] is the variable substrate concentration, *K* ~m~ is the Michaelis constant, *K* ~i~ represents the inhibition constant of a tight binding inhibitor and $K_{i}^{app}$ represents the apparent inhibition constant.

Pre‐steady‐state reaction studies {#febs13690-sec-0017}
---------------------------------

The methylation of AF bound to RosA was investigated at various concentrations of SAM at 25 °C using a spectrophotometer. Briefly, a solution of RosA (20 μ[m]{.smallcaps}) and AF (20 μ[m]{.smallcaps}) in 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8.0, containing 100 m[m]{.smallcaps} NaCl was pre‐incubated at 25 °C for 3 min, and then the reaction was initiated by adding SAM (final concentrations of 80, 200, 400, 1000 and 2000 μ[m]{.smallcaps}). Progress of the reaction due to consumption of AF and formation of the final product (RoF) was monitored at 479 and 530 nm, respectively. Data analysis of the kinetic traces was performed using the exponential equations from [kinetic studio]{.smallcaps} software (TgK Scientific Ltd) to obtain the observed rates (*k* ~obs~). Rate constants were determined from plots of *k* ~obs~ as a function of the SAM concentration using the Levenberg--Marquardt algorithm implemented in the [kaleidagraph]{.smallcaps} software (Synergy Software).

Stopped‐flow spectrophotometric studies {#febs13690-sec-0018}
---------------------------------------

All experiments were performed at 25 °C using an SF‐61SX2 stopped‐flow spectrophotometer (TgK Scientific Ltd, Bradford‐on‐Avon, UK) with a 1 cm path length. Prior to all experiments, the stopped‐flow instrument was flushed with 50 m[m]{.smallcaps} Tris/HCl buffer, pH 8, containing 100 m[m]{.smallcaps} NaCl several times. To analyse the effect of substrate binding order on the reaction kinetics, experiments with different mixing orders of AF and SAM were performed. Various pre‐mixed solutions of RosA, RosA:AF or RosA:SAM complexes were prepared, and then mixed with solutions containing AF and SAM, SAM or AF, respectively. The progress of the reactions was monitored at 479 and 530 nm using a KinetaScan diode array detector (TgK Scientific Ltd).

Product analysis by HPLC {#febs13690-sec-0019}
------------------------

HPLC analysis of AF, MAF and RoF was performed using an Atlantis^®^ dC18 reversed‐phase column (5 μm, 4.6 × 250 mm; Waters, Milford, MA, USA) on an Ultamate 3000 HPLC instrument (Dionex, Sunnyvale, CA, USA) at 25 °C. All samples prepared from RosA reactions were loaded onto the column and eluted using a multi‐step gradient of 100 m[m]{.smallcaps} formic acid and 100 m[m]{.smallcaps} ammonium formate (pH 3.7)/methanol (0--3 min, 30% methanol; 3--20 min, 30--75% methanol; 20--22 min, 75% methanol) at a flow rate of 0.8 mL·min^−1^. Detection of AF, MAF and RoF was performed by measuring the absorption at 479, 490 and 509 nm, respectively.

Crystallization {#febs13690-sec-0020}
---------------

Crystallization drops containing purified native RosA at a concentration of 20 mg·mL^−1^ in 20 m[m]{.smallcaps} Tris/HCl, pH 8.0, 500 m[m]{.smallcaps} NaCl, were set up with commercially available screening solutions using the microbatch method on an Oryx‐7 crystallization robot (Douglas Instruments Ltd, Hungerford, UK) at 293 K. Drops were prepared by mixing equal amounts (1.0 μL) of protein and precipitant. Crystals of native RosA grew within 5 days after mixing the protein solution (in a 1 : 1 ratio) with a solution containing 200 m[m]{.smallcaps} sodium chloride, 100 m[m]{.smallcaps} Tris/HCl, pH 5.5, and 25% w/v PEG‐3350.

The same approach was used to grow crystals of the selenomethionine‐labelled derivative. Equal amounts (0.5 μL) of the variant at a concentration of 20 mg·mL^−1^ in 20 m[m]{.smallcaps} Tris/HCl, pH 8.0, 500 m[m]{.smallcaps} NaCl and 2 m[m]{.smallcaps} β‐mercaptoethanol were mixed with precipitant containing 100 m[m]{.smallcaps} MES/imidazole, pH 6.5, 20 m[m d]{.smallcaps}‐glucose, [d]{.smallcaps}‐mannose, [d]{.smallcaps}‐galactose, [l]{.smallcaps}‐fructose, [d]{.smallcaps}‐xylose and *N*‐acetyl‐[d]{.smallcaps}‐glucosamine, 10% w/v PEG‐20000 and 20% v/v PEG‐MME 550 [28](#febs13690-bib-0028){ref-type="ref"}. SeMet‐RosA crystals grew within 7 days after crystallization set‐up. For diffraction data collection, crystals were harvested from their mother liquor using CryoLoops^™^ (Hampton Research, Aliso Viejo, CA, USA), and flash‐cooled in liquid nitrogen without any additional cryoprotection.

Structure determination and refinement {#febs13690-sec-0021}
--------------------------------------

Diffraction data to a resolution of 2.2 Å were collected for native RosA from a single triclinic crystal (space group *P*1) at beamline ID23‐1 of the European Synchrotron Radiation Facility (Grenoble, France). MAD data to a resolution of approximately 3.5 Å were collected at beamline X06DA‐PXIII of the Swiss Light Source at the Paul Scherrer Institute (Villigen, Switzerland). Three MAD datasets were collected from a single tetragonal SeMet‐RosA crystal (space group *I*4~1~22) at various wavelengths (peak, inflection, remote) that were determined from an X‐ray fluorescence scan recorded around the selenium absorption edge. Data processing and scaling for the native and SeMet MAD datasets were performed using [xds]{.smallcaps} [29](#febs13690-bib-0029){ref-type="ref"}, [scala]{.smallcaps} and [aimless]{.smallcaps} [30](#febs13690-bib-0030){ref-type="ref"}.

The calculated Matthews coefficient [30](#febs13690-bib-0030){ref-type="ref"}, [31](#febs13690-bib-0031){ref-type="ref"} of the MAD datasets indicated a 99.9% probability for the presence of one RosA molecule per asymmetric unit of the crystal. To identify selenium sites, the two MAD pipelines [auto‐rickshaw]{.smallcaps} [32](#febs13690-bib-0032){ref-type="ref"}, [33](#febs13690-bib-0033){ref-type="ref"} and [phenix]{.smallcaps} AutoSol [34](#febs13690-bib-0034){ref-type="ref"}, [35](#febs13690-bib-0035){ref-type="ref"} were used. The combination of these programs yielded first phases and a partial structure. These phases were further used as input phases for the automated chain‐tracing/building programs [phenix autobuild]{.smallcaps} [36](#febs13690-bib-0036){ref-type="ref"} and [buccaneer]{.smallcaps} [37](#febs13690-bib-0037){ref-type="ref"} to extend the model and to improve its quality. The combined model of both rebuilding programs produced interpretable electron densities, with preliminary values of *R* = 37% and *R* ~free~ = 49%. *R* ~free~ values were computed from a set of randomly chosen reflections (5%), which were not used during refinement [38](#febs13690-bib-0038){ref-type="ref"}. Structure refinement was performed using the refinement programs [phenix refine]{.smallcaps} [34](#febs13690-bib-0034){ref-type="ref"} and [refmac]{.smallcaps} [39](#febs13690-bib-0039){ref-type="ref"}. Model rebuilding was performed using [buccaneer]{.smallcaps} [37](#febs13690-bib-0037){ref-type="ref"} and [coot]{.smallcaps} [40](#febs13690-bib-0040){ref-type="ref"} by alternate automated rebuilding and real‐space fitting against σ~A~‐weighted 2 *F* ~o~ *-- F* ~c~ and *F* ~o~ *-- F* ~c~ electron density maps together with least‐squares optimization.

The improved MAD model was used as an initial molecular replacement template for [phaser]{.smallcaps} [41](#febs13690-bib-0041){ref-type="ref"} to determine the structure of native RosA in the triclinic crystal form. Molecular replacement resulted in six molecules in the asymmetric unit. Structure refinement and model building were performed using [phenix refine]{.smallcaps} [34](#febs13690-bib-0034){ref-type="ref"} and [coot]{.smallcaps} [40](#febs13690-bib-0040){ref-type="ref"} by real‐space fitting against σ~A~‐weighted 2*F* ~o~ *-- F* ~c~ and *F* ~o~ *-- F* ~c~ electron density maps and least‐squares optimizations. Water molecules were placed into the difference electron density map, and accepted or rejected on the basis of geometry criteria as well as refined B‐factors. In later stages of the refinement, four TLS groups per protomer were defined based on an analysis using the TLSMD web server [42](#febs13690-bib-0042){ref-type="ref"}. The final model was refined to *R* = 20% and *R* ~free~ = 24%. Validation of the structure was performed using [molprobity]{.smallcaps} [43](#febs13690-bib-0043){ref-type="ref"}, yielding a Ramachandran plot with 97.20% of the residues in favoured regions, 2.65% in allowed regions and 0.15% in disallowed regions. Data statistics and details of structure refinement are given in Table [1](#febs13690-tbl-0001){ref-type="table-wrap"} (MAD data) and Table [2](#febs13690-tbl-0002){ref-type="table-wrap"} (native data).

Prediction of the SAM/SAH binding site {#febs13690-sec-0022}
--------------------------------------

In order to locate putative binding sites for the substrate AF and the cofactor SAM, the program [casox]{.smallcaps} [19](#febs13690-bib-0019){ref-type="ref"} together with the web tools [prosite]{.smallcaps} (sequence‐based prediction) [20](#febs13690-bib-0020){ref-type="ref"}, [3dligandsite]{.smallcaps} (sequence‐ and structure‐based prediction) [21](#febs13690-bib-0021){ref-type="ref"} and [coach]{.smallcaps} (sequence‐ and structure‐based prediction) [22](#febs13690-bib-0022){ref-type="ref"} were used. The results of the cavity analysis using [casox]{.smallcaps} were compared with consensus ligand binding residues predicted by PROSITE, [3dligandsite]{.smallcaps} and [coach]{.smallcaps}. [coach]{.smallcaps} additionally generated putative enzyme--ligand model complexes and ranked them according to an intrinsic C‐score. This C‐score represents a confidence score for the prediction. C‐scores range between 0 and 1, with a higher score indicating a more reliable prediction. The highest‐rated complex, together with other related methyltransferase structures, were superimposed with RosA to identify ligand binding modes. The modelled RosA--ligand complex was further energy‐minimized using the program [yasara]{.smallcaps} with the AMBER03 force field, employing the standard optimization protocol [44](#febs13690-bib-0044){ref-type="ref"}. Structure alignments were performed using [pymol]{.smallcaps} (<https://www.pymol.org/>).
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